Intelligent Bio accelerates global adoption of fingerprint drug testing

Intelligent Bio Solutions (INBS) announced recent growth highlights across its global operations, driven by new account acquisitions, expansion into new testing areas and sectors, and continued penetration into safety-critical industries. The Company’s total number of active accounts has surpassed 450, with 35 new accounts added in fiscal Q3 alone. INBS’ Intelligent Fingerprinting Drug Screening System, which detects recent drug use in under ten minutes through fingerprint sweat analysis, continues to gain traction for its speed, portability, and ease of use. This latest growth aligns with INBS’ strategic localization and international expansion plans, targeting high-demand markets